A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : VKAs

Search Conditions:
Search Keyword : VKAs
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: VKAs
Appearance Frequency: 830 time(s)
Long forms: 10

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
vitamin K antagonists
(817 times)
Vascular Diseases
(201 times)
AF (275 times)
NOACs (217 times)
DOACs (165 times)
2004 Non-fatal major bleeding during treatment with vitamin K antagonists: influence of soluble thrombomodulin and mutations in the propeptide of coagulation factor IX.
vitamin K-antagonist anticoagulants
(4 times)
Cardiology
(1 time)
AF (2 times)
DOACs (2 times)
NOACs (2 times)
2015 Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants versus Vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: A Meta-Analysis.
vitamin K oral anticoagulants
(2 times)
Medicine
(1 time)
DOACs (1 time)
LVT (1 time)
NOACs (1 time)
2018 The potential for evaluating the effects of intensified antithrombotic therapy using retinal optical coherence tomography angiography.
anti-vitamin K agents
(1 time)
Chemistry
(1 time)
BMD (1 time)
DOACs (1 time)
LMWHs (1 time)
2019 Anticoagulants and Osteoporosis.
enoxaparin-vitamin K antagonists
(1 time)
Hematology
(1 time)
--- 2016 Risk of major bleeding in patients with venous thromboembolism treated with rivaroxaban or with heparin and vitamin K antagonists.
Vit K antagonists
(1 time)
Cardiology
(1 time)
AF (1 time)
DOACs (1 time)
HHF (1 time)
2018 Better clinical outcome with direct oral anticoagulants in hospitalized heart failure patients with atrial fibrillation.
vitamin K analogues
(1 time)
Health Services
(1 time)
CAT (1 time)
DOACs (1 time)
IDPTP (1 time)
2017 Advances in managing and preventing thromboembolic disease in cancer patients.
vitamin K inhibitors
(1 time)
Drug Therapy
(1 time)
ADRs (1 time)
DOACs (1 time)
2020 What are the Characteristics of Patients Experiencing Adverse Drug Reactions to Oral Anticogulants and How Can Such Reactions be Prevented?
Vitamin K-dependent antagonists
(1 time)
Cardiology
(1 time)
NOACs (1 time)
2016 Real Data on Effectiveness, Tolerability and Safety of New Oral Anticoagulant Agents: Focus on Dabigatran.
10  vitamin K-dependent, drugs interfering with the effects of the vitamin
(1 time)
Hematology
(1 time)
ACS (1 time)
NOACs (1 time)
TXA2 (1 time)
2016 Individualized antithrombotic therapy.